A non-catalytic function for Rad18 in sustaining glioblastoma proliferation
Benbahouche, N. E.-H.; Kermi, C.; Siegfried, A.; Sefancikova, L.; Pascussi, J.-M.; Pannequin, J.; Moreaux, J.; Hugnot, J.-P.; Delisle, M.-B.; Moyal, E.; Uro-Coste, E.; Maiorano, D.
Show abstract
The Rad18 E3 ubiquitin ligase, a non-essential gene, is a key regulator of DNA damage tolerance that also functions in repair of DNA double strand breaks. Rad18 is overexpressed in the aggressive brain cancer glioblastoma (GBM) and its downregulation sensitizes glioblastoma cells to DNA damaging agents. Here we show that Rad18 has an essential role in GBM cells proliferation in the absence of external damage, surprisingly independent of its catalytic activity. Rad18 downregulation leads to cell cycle arrest in the G1 phase in the absence of apparent DNA damage. We also show that Rad18 sustains GBM stem cells self-renewal and survival, as well as the growth of tumor orthotropic xenografts in mice. We also show that increased Rad18 expression enhances the growth of non-transformed cells and induces features of oncogenic transformation. Mechanistically, we show that Rad18 downregulation negatively regulates the Hippo pathway by interfering with the nuclear retention of the YAP1 transcription factor. Altogether, these data show that Rad18 has an essential, non-catalytic function, in GBM proliferation, and propose Rad18 as a key target to sensitize GBM to therapy.
Matching journals
The top 14 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Development of an optimized, non-stem cell line for intranasal delivery of therapeutic cargo to the central nervous system 95%
- NOX4 regulates TGFβ-induced proliferation and self-renewal in glioblastoma stem cells. 95%
- Heterogeneity of RNA editing in mesothelioma and how RNA editing enzyme ADAR2 affects mesothelioma cell growth, response to chemotherapy and tumor microenvironment 95%
Similar papers in this journal
- Leveraging Allele-Specific Expression for Therapeutic Response Gene Discovery in Glioblastoma. 95%
- Therapy-induced transdifferentiation promotes glioma growth independent of EGFR signaling 94%
- Hypoxia Drives Dihydropyrimidine Dehydrogenase Expression in Macrophages and Confers Chemoresistance in Colorectal Cancer 93%
Similar papers in this journal
- EMP3 sustains oncogenic EGFR/CDK2 signaling by restricting receptor degradation in glioblastoma 94%
- MiR-212-3p functions as a tumor suppressor gene in group 3 medulloblastoma via targeting Nuclear Factor I/B (NFIB) 94%
- Capture at the single cell level of metabolic modules distinguishing aggressive and indolent glioblastoma cells 94%
Similar papers in this journal
Similar papers in this journal
- Loss of EIF4G2 Mediates Aggressiveness in Distinct Human Endometrial Cancer Subpopulations with Poorer Survival Outcome in Patients 94%
- The long non-coding RNA SAMMSON is essential for uveal melanoma cell survival 94%
- Targeting the MYC interaction network in B-cell lymphoma via histone deacetylase 6 inhibition 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.